Stock BALPHARMA BAL PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Bal Pharma Limited

Equities

BALPHARMA

INE083D01012

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 03:30:53 28/06/2024 pm IST 		5-day change 1st Jan Change
117.5 INR +0.69% Intraday chart for Bal Pharma Limited -1.96% +16.92%
28/06 Bal Pharma Limited Announces the Cessation of C. V. Srinivas as Independent Director, Chairman/Member of the Audit Committee, Nomination and Remuneration Committee, Stake Holders Relationship Committee & Corporate Social Responsibility Committees CI
28/05 Bal Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI

Business Summary

Bal Pharma Limited is a pharmaceutical company, which is engaged in manufacturing and selling of pharmaceutical products. The Company is engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients (API). It is specialized in prescription drugs, generic & OTC products, intravenous infusion, and bulk actives. The Company offers range of APIs includes antihistamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, and others. It also offers range of formulations products covering dosage forms-tablets, capsules, syrups, suspensions, IV infusions, ophthalmic, creams and ointments to various semi-regulated markets. The API products are being exported to Japan, Australia, Spain, the United Kingdom, Canada, Nigeria, Iceland, Slovenia, Romania, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, among others.

Number of employees: 869

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical Formulations and Active Pharmaceutical Ingredients
99.1 %
2,797 99.5 % 3,016 99.1 % +7.83%
Other
0.8 %
15 0.5 % 25 0.8 % +65.54%
Services
0.0 %
0 0.0 % 1 0.0 % +5,385.71%

Sales per region

INR in Million2022Weight2023Weight Delta
India
100.0 %
2,812 100.0 % 3,042 100.0 % +8.18%

Managers

Managers TitleAgeSince
Shailesh Dheerajmal Siroya CEO
 Chief Executive Officer - 01/94/01
Daddanala Bharath Bhushan DFI
 Director of Finance/CFO - 02/23/02
Abdul Basith CMP
 Compliance Officer - 17/23/17
M. P. George COO
 Chief Operating Officer - 10/12/10

Members of the board

Members of the board TitleAgeSince
Shailesh Dheerajmal Siroya CEO
 Chief Executive Officer - 01/94/01
C. V. Srinivas BRD
 Director/Board Member 58 29/19/29
Himesh Virupakshaya BRD
 Director/Board Member - 28/19/28
H. S. Venkatesh BRD
 Director/Board Member - 23/20/23
Nicola Neeladri BRD
 Director/Board Member - 23/20/23
Jatish Sheth BRD
 Director/Board Member - 28/20/28
Kotian Chittananda Damodar BRD
 Director/Board Member 63 30/22/30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 15,804,372 5,327,032 ( 33.71 %) 0 33.71 %

Company contact information

Bal Pharma Ltd.

Lakshmi Narayan Complex 10/1, Palace Road

560052, Bangalore

+91 80 4137 9500

http://www.balpharma.com
address Bal Pharma Limited(BALPHARMA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
BAL PHARMA LIMITED Stock Bal Pharma Limited
+16.92% 21.94M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 819B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 329B
ABBVIE INC. Stock AbbVie Inc.
+10.68% 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+2.04% 225B
NOVARTIS AG Stock Novartis AG
+13.31% 217B
AMGEN INC. Stock Amgen Inc.
+8.48% 168B
PFIZER, INC. Stock Pfizer, Inc.
-2.81% 158B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BALPHARMA Stock
  4. Company Bal Pharma Limited